Innovation in the healthcare sector in New York is exciting and extensive. Please join us to meet startups, CEOs, investors and industry experts at Invest NY: Health & Wellbeing. The event will be held on January 28 online. You’ll have the chance to
Meet innovative startups Hear from active investors Learn from industry experts Build your personal network
Agenda & Speakers
Startup & Investor Showcase – three minute pitches from startups innovating in New York
Group Networking – hosted by Upstate Capital
Upstate Capital Welcome
Keynote Conversation: Vikram Agrawal, president and CEO, Levrx
Vikram Agrawal serves as President, CEO, & Co-Founder of Levrx. In his role, Vikram is responsible for the vision, product strategy, and business development. Vikram’s previous experience in business and information technology fields is critical to the success of Levrx.
State of the Industry: Jason Helgerson – Helgerson Solutions
Helgerson Solutions Group
Jason Helgerson founded Helgerson Solutions Group and serves as its Chief Executive Officer, leading the firm’s mission of making the world a better place. Jason also leads the firm’s portfolio of venture capital and private equity advising, as well as engaging in international comparative work, bringing the best ideas to change-makers across the globe.
Building Opollo in Buffalo, Ryan Young, founder of Opollo with Christina Orsi, University of Buffalo and Clayton Besch, New York Ventures
Ryan Young is the Founder & CEO of Opollo Technologies, a healthcare technology startup. The company’s flagship product, Opollo™, is a deep neural network which also utilizes medical natural language processing to provide the most accurate surgery duration forecasts on the market today.
New York Ventures
Clayton Besch is the Director of ESD’s New York Ventures which works to bolster the critical capital needs of New York State’s innovation economy by providing seed and early-stage venture funding to high growth startups as they move from concept to commercialization, through early growth and expansion.
University at Buffalo
Christina Orsi serves at the Associate Vice President for Economic Development at the University at Buffalo (UB). UB is among the largest and most comprehensive research Universities in New York State. Bringing more than two decades of experience in economic development, she guides university-wide economic development efforts.
Investing in Life Sciences in NYC with Maria Gotsch, Partnership Fund for NYC and Sharon Rutter, NY Ventures
Partnership Fund for New York City
Maria G. Gotsch is President and Chief Executive Officer of the Partnership Fund for New York City, which is the investment arm of the Partnership for New York City. The Fund, which has invested over $170 million, has built a network of top experts from the investment and corporate communities who help identify and support NYC’s most promising entrepreneurs in both the for-profit and non-for profit sectors.
Sharon Rutter currently serves as Senior Director, NY Ventures operating out of New York State’s economic development agency (“ESD”). Rutter successfully designed and managed the Innovate NY Fund, a $45 million fund-of-funds funded with $35 million of federal program funds and $10 million from Goldman Sachs.
Introduction to the Masonic Medical Research Institute, with Maria Kontaridis
Masonic Medical Research Institute
Dr. Maria Irene Kontaridis is currently the Director of Research at the Masonic Medical Research Institute in Utica, NY. She also holds a part-time faculty appointment as an Associate Professor of Medicine at Harvard Medical School and Beth Israel Deaconess Medical Center, Department of Medicine/Division of Cardiology in Boston, MA.
Scalable regional partner for entrepreneurs and biotechs: Trudeau in the North Country, with Atsuo Kuki, Ph.D.
Dr. Atsuo Kuki joined the Trudeau Institute in 2016 as President and Director bringing a passion for transformational leadership in biomedical science and technology.
Investor Perspectives with Lindsay Stencel of Thompson Hine LLP, Theresa Mazzullo of Excell Partners, Somak Chattopadhyay of Armory Square Ventures and Brian Model of Topmark Partners
Lindsay Karas Stencel
Lindsay Karas Stencel has been in venture capital for nearly 15 years. She is a Partner at Thompson Hine LLP running the VC and Emerging Companies group in Columbus where she focuses on growing venture capital, and increasing capital access generally, for entrepreneurs throughout the Midwest, representing venture firms and startups from Albany to Chicago.
Brian Model is a Growth Stage Venture Capitalist focused predominantly on high potential business-to-business technology-enabled companies based in up-and-coming regions. He is a Managing Partner and is responsible for the overall operations of Topmark Partners, including sourcing, underwriting, and executing the firm’s growth equity investments.
Theresa Mazzullo has been the CEO of Excell Partners since 2006. She has a 30-year track record in business, finance and entrepreneurship. Having owned and sold a small business, she brings firsthand knowledge, unique skills, and proven experience to the seed stage investment arena. Her duties include governance, compliance, reporting, community integration, finance and fundraising.
Armory Square Ventures
Somak Chattopadhyay has been operating and investing in early-stage startups in New York State and other emerging venture regions since 1999. Before launching Armory Square Ventures in 2014, he was a partner at Tribeca Venture Partners, where he was instrumental in nearly every investment of its first fund and helped launch its second fund.
Souvik Paul – CEO – CathBuddy
At CathBuddy, Inc., we are improving the standard of care and reducing UTI incidence for intermittent catheter users.
We believe that individuals on the autism spectrum can lead a fulfilling and productive life. That is why JelikaLite is developing Cognilum™, an innovative solution to permanently reduce a child’s autism symptoms, enabling better integration into society.
Our goal with VitalMask is to change the way that the ED boarding process is completed, and how the waiting room is underutilized as an important area for data collection and monitoring. Without having to increase the number of nurses, an ED administrator can reduce the risk of a patient’s condition unnoticeably worsening as they wait for care, as well as decrease the rate of walkouts due to lack of care.
ZEPHYRx LLC’s seeks to empower patients to actively manage and improve their own health, both in-hospital and at home, through leading-edge technology including remote patient monitoring, video games and virtual reality.
Glauconix Biosciences is a specialty pharma research company that uses an innovative platform technology to reduce the cost of ophthalmic drug development. Glauconix operates out of its laboratories located at the SUNY Polytechnic Institute-Albany, NY campus.
Our mission, as the developer and distributor of Quikiks, the world’s first securely fastening hands-free footwear, is to provide people of limited physical or cognitive ability more independence, a better quality-of-life and increased safety.
Opollo Technologies is a healthcare startup company. Their flagship product Opollo™, is a deep neural network which also utilizes medical natural language processing to provide the most accurate surgery duration forecasts on the market today.
ResET Water uses an Electrochemical Oxidation (EO) process to safely and effectively remove harmful algal blooms (HABs) from water bodies. This technology allows landowners, lake associations, and local communities that rely on water services to have peace of mind that they can enjoy their body of water safely and obtain all benefits and ecosystem services that local water bodies offer.
Vü’s mission is to enable those with hearing loss and other communication disorders to live, learn and work independently in the real world. They are the winner of the recent Startup Grind Rochester pitch competition (Dec. 2020) and have two patent-pending smart devices under development.
Channavix is a start-up biotech company dedicated to the discovery of novel therapeutics for neurological disorders such as pain. Our mission is to improve patient pain management by developing local, targeted, long-lasting and non-addictive painkillers. Our proprietary technology relies on new biological insights and a new unique mechanism of action, leading to innovative therapies for pain management.
Rong Zhao – CEO & Co-Founder – Orchid Imaging, Inc
Orchid Imaging, Inc.
Orchid Imaging is a technology startup commercializing high-speed and high-resolution 3D scanning technology and advanced geometric modeling algorithms. We develop innovative applications for healthcare, cosmetics, computer games, entertainment, manufacturing, and other industries.